Identification of potential miRNAs biomarkers for high-grade prostate cancer by integrated bioinformatics analysis
L Foj, X Filella - Pathology & Oncology Research, 2019 - Springer
The increasing number of datasets available in the GEO database offers a new approach to
identify new miRNAs related to PCa. The aim of our study was to suggest a miRNA signature …
identify new miRNAs related to PCa. The aim of our study was to suggest a miRNA signature …
Identification of candidate miRNAs in early-onset and late-onset prostate cancer by network analysis
The incidence of patients under 55 years old diagnosed with Prostate Cancer (EO-PCa) has
increased during recent years. The molecular biology of PCa cancer in this group of patients …
increased during recent years. The molecular biology of PCa cancer in this group of patients …
Identification of microRNA and gene interactions through bioinformatic integrative analysis for revealing candidate signatures in prostate cancer
MM Khan, M Serajuddin, MZ Malik - Gene Reports, 2022 - Elsevier
Abstract Background Prostate cancer (PCa) is a most common diagnosed cancer among
males globally. Despite the decreased PCa mortality, increased prevalence of it creates …
males globally. Despite the decreased PCa mortality, increased prevalence of it creates …
Identification of the Key MicroRNAs and the miRNA‐mRNA Regulatory Pathways in Prostate Cancer by Bioinformatics Methods
D Li, X Hao, Y Song - BioMed Research International, 2018 - Wiley Online Library
Objective. To identify key microRNAs (miRNAs) and their regulatory networks in prostate
cancer. Methods. Four miRNA and three gene expression microarray datasets were …
cancer. Methods. Four miRNA and three gene expression microarray datasets were …
Identification of microRNAs as viable aggressiveness biomarkers for prostate cancer
LJ Martínez-González, V Sánchez-Conde… - Biomedicines, 2021 - mdpi.com
MiRNAs play a relevant role in PC (prostate cancer) by the regulation in the expression of
several pathways' AR (androgen receptor), cellular cycle, apoptosis, MET (mesenchymal …
several pathways' AR (androgen receptor), cellular cycle, apoptosis, MET (mesenchymal …
[PDF][PDF] Expression profile analysis reveals putative prostate cancer-related microRNAs
H Song, Y Liu, J Pan, ST Zhao - Genet Mol Res, 2013 - m.jstshuichan.com
Annotation of prostate cancer (PC) genomes provides a foundation for discoveries that can
improve the understanding and treatment of the disease. Therefore, in the present study, we …
improve the understanding and treatment of the disease. Therefore, in the present study, we …
In-Silico integration approach to identify a key miRNA regulating a gene network in aggressive prostate cancer
Like other cancer diseases, prostate cancer (PC) is caused by the accumulation of genetic
alterations in the cells that drives malignant growth. These alterations are revealed by gene …
alterations in the cells that drives malignant growth. These alterations are revealed by gene …
Screening biomarkers of prostate cancer by integrating microRNA and mRNA microarrays
J Feng, C Huang, X Diao, M Fan, P Wang… - Genetic testing and …, 2013 - liebertpub.com
Objective: In this study, we screened microRNA (miRNA) target genes of prostate cancer by
integrating miRNA and mRNA expression profiles after target prediction and performed …
integrating miRNA and mRNA expression profiles after target prediction and performed …
Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 expression as biomarker for prostate cancer diagnosis
L Moya, J Meijer, S Schubert, F Matin… - International journal of …, 2019 - mdpi.com
Prostate cancer (PCa) is one of the most commonly diagnosed cancers worldwide,
accounting for almost 1 in 5 new cancer diagnoses in the US alone. The current non …
accounting for almost 1 in 5 new cancer diagnoses in the US alone. The current non …
RETRACTED ARTICLE: Dysregulation of cell cycle related genes and microRNAs distinguish the low-from high-risk of prostate cancer
J Wen, R Li, X Wen, G Chou, J Lu, X Wang, Y Jin - Diagnostic Pathology, 2014 - Springer
Abstract Background Prostate cancer (PCa) is a biologically heterogeneous disease with
considerable variation in clinical aggressiveness. In this study, bioinformatics was used to …
considerable variation in clinical aggressiveness. In this study, bioinformatics was used to …
相关搜索
- high grade prostate cancer
- bioinformatics analysis prostate cancer
- mirnas biomarkers prostate cancer
- biomarker for prostate cancer diagnosis
- screening biomarkers prostate cancer
- identification of microrna prostate cancer
- gene interactions prostate cancer
- gene network prostate cancer
- network analysis prostate cancer
- aggressive prostate cancer
- candidate signatures prostate cancer
- regulatory pathways prostate cancer
- cell cycle prostate cancer
- late onset prostate cancer
- prostate cancer evolution
- early onset prostate cancer